Genmab announced that its Phase 3 RAINFOL-02 trial of rinatabart sesutecan (Rina-S®) met primary and key secondary endpoints, showing statistically significant and clinically meaningful improvements in progression-free survival (PFS) and overall survival (OS) for patients with platinum-resistant ovarian cancer. The trial included 584 patients regardless of folate receptor alpha expression, with Rina-S reducing the risk of disease progression or death by 71% in the intent-to-treat population. Safety results were consistent with known profiles, with no new safety concerns. Genmab plans to discuss these results with regulatory authorities and present data at future medical meetings, advancing its goal to offer new treatment options for this challenging cancer type.
Genmab's announcement on Rinatabart Sesutecan (Rina-S®) highlights progress in ovarian cancer treatment. For readers following the health sector, here is Pluang's market snapshot as of Oct 23, 2026 21:32 WIB: out of 150 priced US health stocks, 19 rose and 130 fell. Notable movers include SYRE at USD 89.10 with a 1-day change of -3.50% and Pluang order activity of 89% Buy, ADMA at USD 10.58 with a 1-day change of -3.38% and 100% Buy order activity, and ERAS at USD 13.57 with a 1-day change of -3.35%.
With U.S. crude oil prices above $100 a barrel, investors are shifting focus to smaller companies with promising technologies and upcoming catalysts. Kraig Biocraft Laboratories shipped its first commercial spider silk yarn order, moving toward scala...
FS Bancorp, Inc. has appointed Matthew D. Mullet as a director on the boards of both the company and its bank, 1st Security Bank of Washington, effective October 22, 2026. Mullet, who has been President since 2024 and CEO since 2025-2026, brings exte...
The global protein ingredients market, valued at $42.3 billion in 2025, is projected to grow to $65 billion by 2032 with a CAGR of 6.3%. Growth is driven by rising consumer demand for health-focused, protein-enriched foods, sports nutrition, and sust...
AX1 has launched Console 2.0, a platform on the Base blockchain that lets AI agents perform tasks and get paid in USDC using the x402 payment standard by Coinbase. This new version simplifies setup, allowing users to deploy AI agents quickly to work ...
The global generator cooling systems market is projected to grow from $3.76 billion in 2026 to $5.03 billion by 2031 at a CAGR of 6.0%. Growth is fueled by rising demand for reliable backup and continuous power in expanding data centers, industrial f...
